Vaporin Inc (VAPO) 1.9500 $VAPO SciVac Therapeutics

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Vaporin Inc (VAPO) 1.9500 $VAPO

SciVac Therapeutics Inc.: News Release
Marketwired - Mon May 02, 4:31PM CDT
SciVac Therapeutics Inc. ("SciVac" or the "Company" (TSX: VAC)(OTCQX: SVACD) today announced, in connection with the previously disclosed proposed business combination between SciVac and VBI Vaccines Inc., an updated biography for SciVac's Chief Financial Officer, James J. Martin.
VAC.TO: 5.76 (+0.56), VBIV: 4.30 (+0.28)

Vapor Corp. Signs Definitive Merger Agreement with Vaporin, Inc.
PR Newswire - Thu Dec 18, 7:00AM CST
Vapor Corp. (NASDAQ CM: VPCO; "Vapor", a leading U.S. based vaporizer and electronic cigarette company whose brands include emagine vaporTM, Krave®, VaporX®, Hookah Stix®, Alternacig®, and Fifty-One®, announced today the signing of a definitive agreement to merge with Vaporin, Inc. (OTCQB: VAPO; "Vaporin", a distributor and marketer of vaporizers, tanks, mods ("VTM's" and e-liquid products, whereby Vapor will be the surviving entity. At the effective time of the merger, all issued and outstanding shares of Vaporin common stock will be converted into the right to receive the number of shares of Vapor common stock such that former Vaporin stockholders will collectively hold approximately 45% of the issued and outstanding shares of Vapor common stock immediately following consummation of the merger.

American Cannabis Helps Navigate the Cannabis Industry
ACCESSWIRE - Mon Dec 08, 8:55AM CST
WHITEFISH, MT / ACCESSWIRE / December 8, 2014 / The U.S. cannabis industry could be worth $35 billion in 2020 if all 50 states legalized the drug and the federal government ended its prohibition, according to a report from GreenWave Advisors. Even if the federal government doesn't end prohibition and the trajectory of legalization continues on its path, the industry could still reach $20 billion in size by the analyst's estimate.
GWPH: 85.71 (-0.51), TWD.VN: 1.810 (-0.020)

Vaporin Unveils New Vape Store
Marketwired - Tue Nov 25, 7:02AM CST
Vaporin, Inc. (OTCQB: VAPO), is a distributor and marketer of vaporizers, tanks, mods (VTM's) and e-liquids products, today announced unveiling the Company's fifth Vape Store. The Vape Store is located in Ft Myers, Florida and is the first stand-alone building. The Company held a soft opening on November 7, 2014 followed by the Grand Opening on Saturday, November 22, 2014.

Vaporin Receives the Harold Levinson Associates 2014 Annual Vendor of the Year Award in the Vapor Category
Marketwired - Wed Nov 19, 3:24PM CST
Vaporin, Inc. (OTCQB: VAPO) is a distributor and marketer of vaporizers, tanks, mods (VTM's) and e-liquids products, today announced receiving the Harold Levinson Associates (HLA) 2014 Annual Vendor of the Year Award in the Vapor Category at the 2014 Fall Buying Show in White Plains, New York.

Vaporin Announces Sequential Revenue Growth of 100% for the 2014 Third Quarter Ending September 30, 2014
Marketwired - Wed Nov 12, 7:21AM CST
Vaporin, Inc. (OTCQB: VAPO), is a distributor and marketer of vaporizers, tanks, mods (VTM's) and e-liquids products, today announced its financial results for the third quarter and nine month period ending September 30, 2014.

Vapor Corp. Announces Execution of a Term Sheet to Merge with Vaporin, Inc. and Releases Certain Preliminary Third Quarter Financial Results
PR Newswire - Thu Nov 06, 4:37PM CST
Vapor Corp. (NASDAQCM: VPCO) ("Vapor" or the "Company", a U.S.-based vaporizer and electronic cigarette company, announced today, that it has executed a binding term sheet ("Term Sheet" to enter into a merger with Vaporin, Inc. (OTCQB: VAPO) ("Vaporin", a company whose primary focus is in vaporizers and eliquids.

Vaporin Announces Proposed Merger With Vapor Corp.
Marketwired - Thu Nov 06, 3:34PM CST
Vaporin, Inc. (OTCQB: VAPO) ("Vaporin", a distributor and marketer of vaporizers and e-liquids products, announced today that it has executed a binding term sheet (the "Term Sheet" to enter into a merger with Vapor Corp. (NASDAQ: VPCO) ("Vapor", a U.S.-based vaporizer and electronic cigarette company.

Vaporin, Inc. Continues to See Increased Sales Growth as the Vaporizer Segment Surpasses E-Cig Sales
Marketwired - Thu Oct 23, 7:39AM CDT
Vaporin, Inc. (OTCQB: VAPO), a distributor and marketer of vaporizers, tanks, mods (VTM's) and e-liquids products, today announced the Company continues to see a strong increase in sales and revenue as VTM's and the e-liquids industry exceeded electronic cigarette sales for the first time by half a billion dollars.
WFC: 46.85 (+0.07)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 61

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 69

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 181

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 28

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 80

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 149

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 252

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 331

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Warner Bros. Discovery's Remarkable Stock Surge Explained

Updated Category News Views 309

Warner Bros. Discovery Experiences Impressive Stock Surge Warner Bros. Discovery Inc. (NASDAQ: WBD) has been making headlines recently, with its stock surging dramatically. Investors and market enthusiasts are keenly observing this upward trend, particularly following a substantial rally. Record-Breaking Rally The company achieved an incredible milestone with its largest...

Continue Reading
Stellantis Reports 20% Q3 Shipment Drop, Market Reactions

Updated Category News Views 98

Stellantis Faces Significant Q3 Shipment Decline Stellantis (EPA: STLAM) (NYSE: STLA) recently reported a 20% drop in global shipments for the third quarter, prompting a notable reaction in the markets. The decline has been attributed to several factors including strategic inventory reduction measures and delays in the release of new models. During this challenging...

Continue Reading
Stifel Affirms Buy Rating on Elanco Amid New Drug Approval

Updated Category News Views 70

Stifel Stands Firm on Elanco Animal Health Stifel, a prominent financial services firm, has recently reaffirmed its Buy rating for Elanco Animal Health (NYSE: ELAN) and has kept its price target at $20.00 per share. This decision comes on the heels of the U.S. Food and Drug Administration's (FDA) approval of Elanco's new drug, Zenrelia, which serves as a significant boost...

Continue Reading
ChargePoint and Siemens Drive EV Infrastructure Innovation

Updated Category News Views 94

ChargePoint and Siemens Lead the Charge in Clean Tech The clean tech revolution is moving at an impressive pace, particularly with the growth of electric vertical takeoff and landing (eVTOL) aircraft and electric vehicle (EV) infrastructure. Companies like ChargePoint Holdings Inc (NYSE: CHPT) and Siemens AG (OTCPK: SIEGY) are crucial in shaping a sustainable future for...

Continue Reading
Elevance Health Faces Class Action: Investors Seek Remedies

Updated Category News Views 259

Opportunities for Investors in Elevance Health Class Action The recent developments surrounding Elevance Health, Inc. have prompted considerable attention, particularly among investors who have experienced substantial financial losses. The law firm Robbins Geller Rudman & Dowd LLP has initiated a class action lawsuit targeting Elevance Health, which operates in the health...

Continue Reading